Template:Neonatal conjunctivitis treatment: Difference between revisions
| Line 22: | Line 22: | ||
*Acyclovir 20mg/kg IV q8hr x 14-21d | *Acyclovir 20mg/kg IV q8hr x 14-21d | ||
*Topical antiviral | *Topical antiviral | ||
*Do not give steroids | |||
*Full [[neonatal sepsis]] evaluation | *Full [[neonatal sepsis]] evaluation | ||
*Immediate ophtho consult | *Immediate ophtho consult | ||
Revision as of 21:09, 20 June 2019
Prophylaxis
Erythromycin 0.5% ointment x1 or Tetracycline 1% or Silver Nitrate 1% x1 topical, applied at birth.
Chemical
- Watchful waiting
Gonococcal (onset 2-4 days)
- Cefotaxime 100mg/kg IV or IM OR ceftriaxone 25-50mg/kg IV or IM x1 (not to exceed 125mg)
- Cefotaxime is preferred because it does not displace bilirubin
- Disseminated disease should be suspected until CSF is negative
- Admit all infants for evaluation of disseminated disease (BCx, UA/UCx, CSF) and ophthalmology consult given high risk
- Treat mother and partners
- Irrigate eyes with saline (topical antibiotics are insufficient and unnecessary)
Chlamydia (onset 5-10 days)
- erythromycin ophthalmic ointment plus one of the following
- Azithromycin 20mg/kg PO once daily x 3 days OR
- Erythromycin 50mg/kg PO QD in 4 divided doses x 14 days
- Disease manifests 5 days post-birth to 2 weeks (late onset)
Herpetic (onset 6-14 days)
- Acyclovir 20mg/kg IV q8hr x 14-21d
- Topical antiviral
- Do not give steroids
- Full neonatal sepsis evaluation
- Immediate ophtho consult
